Hearscape
← Companies
Sponsor / Institution

City of Hope Medical Center

Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.

All ProgramsTherapeuticsDevices
Open filtered programs
Programs
1
linked to organization
Strong Evidence
0
0 status confirmed
Details Checked
1
0 open data checks
Company / Institution Links
0 / 1
industry vs non-industry records
Competitive Density
3
Pipeline Velocity
70
Completion Signal
0

Programs by Stage

Phase 11

Trial / Program Status

Active1

Modality Mix

Small Molecule1

Indication Coverage

Cisplatin-Induced Hearing Loss1
Hearing Loss1
Ototoxicity1

Program Types

Therapeutic1

Population Tags

adult1
cisplatin-ototoxicity1
otoprotection1
pedmark1
testicular-cancer1

Strong-Evidence Records

0 records
No strong-evidence records are linked to this organization yet.

Checked Records With Caveats

1 checked · 0 open checks
City of Hope Pedmark adult testicular-cancer otoprotection study
Details checked
Small MoleculePhase 1Active

Intravenous Pedmark/sodium thiosulfate administered 6 hours after cisplatin to reduce cisplatin-induced ototoxicity in adult men receiving cisplatin-based chemotherapy for metastatic testicular germ cell tumors.

Data checks: institution-led-study, active-recruiting